<DOC>
	<DOCNO>NCT00336921</DOCNO>
	<brief_summary>The primary objective study assess efficacy alfuzosin 10mg daily return successful void removal catheter follow first episode acute urinary retention ( AUR ) patient suffer benign prostatic hyperplasia ( BPH ) .</brief_summary>
	<brief_title>Alfuzosin Treating Acute Urinary Retention</brief_title>
	<detailed_description />
	<mesh_term>Urinary Retention</mesh_term>
	<mesh_term>Alfuzosin</mesh_term>
	<criteria>First episode painful AUR relate BPH require catheterization Residual volume 500ml 1500ml obtained time catheterization first one hour catheterization Participated another investigational study within 3 month recruitment Suspect bladder neurodysfunction unrelated etiology ; Single Bladder neck disease ; Acute/chronic prostatitis ; Diagnosed prostate carcinoma ; Suspected prostate carcinoma diagnose ultrasound wave ; Surgical history prostate urethra ; Diagnosed/suspected abnormality urethra structure ; Bladder stone ; Blood urine retention cause reason ; Residual volume le 500 ml Residual volume 1500 ml AUR due BPH Parkinson 's disease Insulin dependent diabetes Known/suspected multiple sclerosis ; Stroke/MI within 6 month prior enrolment ; AST , ALT Creatinine &gt; 1.5x upper limit ; neutrophil &lt; 3,000/mm³ ; platelet &lt; 100,000/mm³ ; Unstable/severe heart failure ; History postural hypertension/hypotension ; Known hypersensitivity αreceptor blocker ; Suspected/diagnosed expansible nerval disease ; Treatment sympathomimetic agent within 1 week prior enrolment , except OTC drug cold intermittently ; Treatment α1receptor blocker within 1 month prior enrolment ; Treatment tricyclic antidepressant , anticholinergic agent , sympathomimetic agent ( reason ) , first generation antihistaminic , except treatment stable β sympathomimetic agent/ anticholinergic agent last 1 week Asthma COPD ( Chronic Obstructive Pulmonary Disease ) ; Treatment Disopyramide The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>